Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CENTENE CORPCNC · Entity 3133 | Chief Financial Officer | March 15, 2026 | March 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CENTENE CORP
Report date March 15, 2026 · Filed March 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 747,989.48 |
Reported balance
After 2026-03-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-03-15 · Tax withholding · Disposed 15,241 · Balance 747,989.48 F1: Shares withheld for taxes upon vesting of previously-reported grants of restricted stock units. F2: Ownership includes 448,650 shares of previously-granted restricted stock units and performance stock units (reported at target level performance) subject to vesting requirements. |
| Common Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $81.85 · Expires 2031-12-15 | Direct | 13,449 |
Reported balance
Holding disclosure · report date 2026-03-15 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 13,449 F3: Performance Stock Option granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if the closing price of CNC's common stock equals or exceeds $100 per share for 20 consecutive trading days following the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for taxes upon vesting of previously-reported grants of restricted stock units.
F2: Ownership includes 448,650 shares of previously-granted restricted stock units and performance stock units (reported at target level performance) subject to vesting requirements.
F3: Performance Stock Option granted on December 15, 2021, may become exercisable on or after the third anniversary of the grant date if the closing price of CNC's common stock equals or exceeds $100 per share for 20 consecutive trading days following the grant date.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
WELLCARE HEALTH PLANS, INC.
Report date January 23, 2020 · Filed January 27, 2020
Section 16 reporting ended · disclosed 2020-01-27. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-01-23 transaction · row 1
1 source rowRow 1 · 2020-01-23 · Disposition to issuer · Disposed 68,782 · Balance 0 F1: Reflects disposition in connection with the Agreement and Plan of Merger (the "Merger Agreement") dated March 26, 2019, by and among WellCare Health Plans, Inc. ("WellCare"), Centene Corporation ("Centene"), Wellington Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Centene ("Merger Sub I"), and other parties thereto, pursuant to which Merger Sub I merged with and into WellCare on January 23, 2020 (the "Effective Time"). Upon the Effective Time, each share of WCG common stock held by the Reporting Person were converted into the right to receive (i) $120.000 in cash and (ii) 3.38 validly issued, fully paid and non assessable shares of Centene's common stock, par value $0.001 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the Agreement and Plan of Merger (the "Merger Agreement") dated March 26, 2019, by and among WellCare Health Plans, Inc. ("WellCare"), Centene Corporation ("Centene"), Wellington Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Centene ("Merger Sub I"), and other parties thereto, pursuant to which Merger Sub I merged with and into WellCare on January 23, 2020 (the "Effective Time"). Upon the Effective Time, each share of WCG common stock held by the Reporting Person were converted into the right to receive (i) $120.000 in cash and (ii) 3.38 validly issued, fully paid and non assessable shares of Centene's common stock, par value $0.001 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2017 Filed Mar 3, 2017 17:20 UTC | WELLCARE HEALTH PLANS, INC. WCG · Entity 152183 | Tax withholdingCommon Stock | 3,185 | $143.97 | $458,544.45 |
DisclosureSEC source: 0001140361-17-010596 · doc1.xml · nonDerivative · entry 2 Asher Andrew Lynn · CIK 0001617763 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,924 F2 · shares: Forfeiture of shares to satisfy tax obligations related to performance stock units that were granted to the Reporting Person on August 29, 2014 and vested on March 1, 2017. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 17:20 UTC | WELLCARE HEALTH PLANS, INC. WCG · Entity 152183 | GrantCommon Stock | 7,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-010596 · doc1.xml · nonDerivative · entry 1 Asher Andrew Lynn · CIK 0001617763 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,109 F1 · kind: Settlement of performance stock units that were granted on August 29, 2014 and vested on March 1, 2017 based upon the achievement of performance goals for the three-year performance period ending December 31, 2016. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 18:04 UTC | WELLCARE HEALTH PLANS, INC. WCG · Entity 152183 | GrantRestricted Stock Units · Derivative | 3,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-005170 · doc1.xml · derivative · entry 1 Asher Andrew Lynn · CIK 0001617763 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,265 Underlying: Common Stock · 3,265 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of WCG common stock. F2 · derivative.exercise_date: The vesting of these restricted stock units, which were granted to the Reporting Person on March 28, 2016, was subject to achievement of performance goals for the 2016 performance period to comply with Internal Revenue Code Section 162(m), as well as continued service through the applicable vesting date. On February 6, 2017, the Compensation Committee of the Issuer's Board of Directors certified that the applicable performance goals had been achieved. As a result, the restricted stock units only remain subject to continued service through the applicable vesting date and vest in approximately equal installments on March 1, 2017, March 1, 2018 and March 1, 2019. Vested shares will be delivered to the Reporting Person upon vest. F2 · derivative.expiration_date: The vesting of these restricted stock units, which were granted to the Reporting Person on March 28, 2016, was subject to achievement of performance goals for the 2016 performance period to comply with Internal Revenue Code Section 162(m), as well as continued service through the applicable vesting date. On February 6, 2017, the Compensation Committee of the Issuer's Board of Directors certified that the applicable performance goals had been achieved. As a result, the restricted stock units only remain subject to continued service through the applicable vesting date and vest in approximately equal installments on March 1, 2017, March 1, 2018 and March 1, 2019. Vested shares will be delivered to the Reporting Person upon vest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.